Christopher J H Porter - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Christopher J H Porter

Showing results (81-90 of 232) with videos related to

Pageof 24

Sort By:

Journal of Pharmaceutical Sciences|January 6, 2004

Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approachGreg A Kossena, William N Charman, Ben J Boyd, et al.

The Journal of Pharmacy and Pharmacology|February 26, 2004

Evaluation of the impact of altered lipoprotein binding conditions on halofantrine induced QTc interval prolongation in an anaesthetized rabbit modelMichelle P McIntosh, Andrew J Batey, Susan J Coker, et al.

Pharmaceutical Research|March 21, 2007

Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogsJean F Cuiné, William N Charman, Colin W Pouton, et al.

Pharmaceutical Research|December 26, 2015

A new in vitro lipid digestion - in vivo absorption model to evaluate the mechanisms of drug absorption from lipid-based formulationsMatthew F Crum, Natalie L Trevaskis, Hywel D Williams, et al.

Journal of Pharmaceutical Sciences|November 6, 2015

Constitutive Triglyceride Turnover into the Mesenteric Lymph Is Unable to Support Efficient Lymphatic Transport of a Biomimetic Triglyceride ProdrugSifei Han, Luojuan Hu, Tim Quach, et al.

Pharmaceutical Research|September 14, 2004

Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulationChristopher J H Porter, Ann Marie Kaukonen, Ben J Boyd, et al.

Pharmaceutical Research|December 3, 2014

Profiling the role of deacylation-reacylation in the lymphatic transport of a triglyceride-mimetic prodrugSifei Han, Luojuan Hu, Tim Quach, et al.

Journal of Cardiovascular Pharmacology|February 27, 2003

Desbutylhalofantrine: evaluation of QT prolongation and other cardiovascular effects after intravenous administration in vivoMichelle P McIntosh, Andrew J Batey, Christopher J H Porter, et al.

Nano Letters|February 19, 2019

Pointing in the Right Direction: Controlling the Orientation of Proteins on Nanoparticles Improves Targeting EfficiencyKen W Yong, Daniel Yuen, Moore Z Chen, et al.

Pharmaceutical Research|October 22, 2003

Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogsShui-Mei Khoo, David M Shackleford, Christopher J H Porter, et al.

Pageof 24

Search research articles

Showing results (81-90 of 232) with videos related to

Sort By:

Pageof 24

Journal of Pharmaceutical Sciences|January 6, 2004

Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approachGreg A Kossena, William N Charman, Ben J Boyd, et al.

The Journal of Pharmacy and Pharmacology|February 26, 2004

Pharmaceutical Research|March 21, 2007

Pharmaceutical Research|December 26, 2015

A new in vitro lipid digestion - in vivo absorption model to evaluate the mechanisms of drug absorption from lipid-based formulationsMatthew F Crum, Natalie L Trevaskis, Hywel D Williams, et al.

Journal of Pharmaceutical Sciences|November 6, 2015

Constitutive Triglyceride Turnover into the Mesenteric Lymph Is Unable to Support Efficient Lymphatic Transport of a Biomimetic Triglyceride ProdrugSifei Han, Luojuan Hu, Tim Quach, et al.

Pharmaceutical Research|September 14, 2004

Pharmaceutical Research|December 3, 2014

Profiling the role of deacylation-reacylation in the lymphatic transport of a triglyceride-mimetic prodrugSifei Han, Luojuan Hu, Tim Quach, et al.

Journal of Cardiovascular Pharmacology|February 27, 2003

Desbutylhalofantrine: evaluation of QT prolongation and other cardiovascular effects after intravenous administration in vivoMichelle P McIntosh, Andrew J Batey, Christopher J H Porter, et al.

Nano Letters|February 19, 2019

Pointing in the Right Direction: Controlling the Orientation of Proteins on Nanoparticles Improves Targeting EfficiencyKen W Yong, Daniel Yuen, Moore Z Chen, et al.

Pharmaceutical Research|October 22, 2003

Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogsShui-Mei Khoo, David M Shackleford, Christopher J H Porter, et al.

Pageof 24